✦ LIBER ✦

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies

✍ Scribed by Jacopo Mariotti; Francesco Spina; Cristiana Carniti; Giovanni Anselmi; Davide Lucini; Antonio Vendramin; Fabrizio Pregliasco; Paolo Corradini

Book ID: 114795712
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 218 KB
Volume: 89
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2012.01793.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody responses against influenza A(H

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals

✍ Mari Strengell; Niina Ikonen; Thedi Ziegler; Anu Kantele; Veli-Jukka Anttila; Il 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 372 KB

Noncontrolled Trial of Monovalent AS03A-

Noncontrolled Trial of Monovalent AS03A-Adjuvanted Vaccine for 2009 Pandemic Influenza A(H1N1) in Long-term Dialysis Patients and Transplant Recipients

✍ Anita Hansen; Sebastian Grund; Gerd Hetzel; Katrin Ivens; Heike Angela Sümmchen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Long-lasting immunogenicity and safety o

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009–2010 seasonal influenza vaccine in young patients with Type 1 diabetes mellitus

✍ G. V. Zuccotti; E. Pariani; A. Scaramuzza; L. Santoro; E. Giani; M. Macedoni; A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Immunogenicity of influenza A(H1N1)pdm09

Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C

✍ Satoko Ohfuji; Wakaba Fukushima; Akihiro Tamori; Kazuhiro Maeda; Akiko Maeda; Yo 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 97 KB

Pandemic whole-virion, Vero-cell-derived

Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation

✍ Heimo Lagler; Selma Tobudic; Michael Ramharter; Katarzyna Elandt; Wolfgang R. Sp 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Long term safety and efficacy of H1N1 va

Long term safety and efficacy of H1N1 vaccine in a single-center cohort of IBD patients treated with immunomodulators and/or anti-TNFα biologics

✍ Nikolaos Kyriakos; Konstantinos Papamichael; Emmanuel Archavlis; George Agalos; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 191 KB